<DOC>
	<DOCNO>NCT00699621</DOCNO>
	<brief_summary>- To prove whether use antiplatelet agent result rapid enlargement hematoma onset acute intracerebral hemorrhage . - To prove efficacy safety platelet transfusion prevention hematoma growth patient stricken acute intracerebral hemorrhage antiplatelet medication .</brief_summary>
	<brief_title>Platelet Transfusion Acute Intracerebral Hemorrhage</brief_title>
	<detailed_description>- Hematoma growth well-known powerful determinant mortality poor outcome intracerebral hemorrhage . - Some observation suggest previous use antiplatelet agent associate rapid hematoma enlargement poor outcome cerebral hemorrhage . - Immediate platelet transfusion patient may prevent hematoma growth also cause thromboembolic complication .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<criteria>either aspirin clopidogrel combination aspirin dipyridamole acute primary ICH &gt; 17 year admit within 6 h onset ICH ICH score &lt; 4 type ICH acute primary intracerebral hemorrhage patient need neurosurgery life expectancy le 3 month due comorbid disorder confirm malignant disease ( cancer ) confirm acute myocardial infarction hepatitis and/liver cirrhosis renal failure infectious disease ( HIV , endocarditis etc . ) current previous hematologic disease woman childbearing age pregnant participation another study within precede 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Intracerebral hemorrhage</keyword>
	<keyword>Hematoma enlargement</keyword>
	<keyword>Antiplatelet agent</keyword>
	<keyword>Platelet transfusion</keyword>
	<keyword>Outcome</keyword>
</DOC>